We found that DMF treatment reduced angiostatic thrombospondin-1 (TSP1) transcript levels in healthy control (HC) and pulmonary hypertension (PH) HPASMCs under normoxic and hypoxic conditions (Fig. 4D). This evidence concerns the gene THBS1 and pulmonary hypertension.